[go: up one dir, main page]

MX2009008030A - Liberacion controlada de activos en la piel. - Google Patents

Liberacion controlada de activos en la piel.

Info

Publication number
MX2009008030A
MX2009008030A MX2009008030A MX2009008030A MX2009008030A MX 2009008030 A MX2009008030 A MX 2009008030A MX 2009008030 A MX2009008030 A MX 2009008030A MX 2009008030 A MX2009008030 A MX 2009008030A MX 2009008030 A MX2009008030 A MX 2009008030A
Authority
MX
Mexico
Prior art keywords
alkylaryl
oligomer
inclusive
alkoxy
actives
Prior art date
Application number
MX2009008030A
Other languages
English (en)
Inventor
Joachim B Kohn
Bozena Michniak
David Devore
Larisa Sheihet
Prafulla Chandra
Priya Batheja
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of MX2009008030A publication Critical patent/MX2009008030A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan composiciones tópicas en donde los compuestos activos para el suministro tópico a través del estrato córneo forman complejos con nanoesferas de un copolímero de tres bloques que tiene una estructura de A-B-A en donde cada bloque de extremo A es un polímero u oligómero soluble en agua, hidrófilo y no tóxico; y el bloque del medio B hidrófobo es un polímero u oligómero hidrófobo con las mismas o diferentes unidades repetidas que tienen la estructura de acuerdo con la fórmula (I) (ver fórmula (I)) en donde X es - C - R - C - o -C-; Z es entre 2 y 100, inclusive; R1 es CH=CH o (CH2)n, en donde n es de 0 a 18, inclusive; R2 se selecciona de hidrógeno y grupos alquilo recto y ramificado, alcoxi, alquilarilo y alcoxiarilo que contiene hasta 18 átomos de carbono; y R se selecciona de un enlace o grupos alquilo recto o ramificado, alcoxi, alquilarilo y alcoxiarilo que contienen hasta 18 átomos de carbono.
MX2009008030A 2007-01-31 2008-01-31 Liberacion controlada de activos en la piel. MX2009008030A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88755307P 2007-01-31 2007-01-31
PCT/US2008/052728 WO2008095144A2 (en) 2007-01-31 2008-01-31 Controlled release of actives in skin

Publications (1)

Publication Number Publication Date
MX2009008030A true MX2009008030A (es) 2009-10-19

Family

ID=39674804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008030A MX2009008030A (es) 2007-01-31 2008-01-31 Liberacion controlada de activos en la piel.

Country Status (8)

Country Link
US (1) US8414871B2 (es)
EP (2) EP3542785A1 (es)
CN (1) CN101668512A (es)
AU (1) AU2008210329B2 (es)
CA (1) CA2676841C (es)
MX (1) MX2009008030A (es)
NZ (1) NZ578693A (es)
WO (1) WO2008095144A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120048003A1 (en) * 2010-08-24 2012-03-01 GOLDEN PRODUCTS LLC, Limited Liability Company Vitamin assay methods
CN102706971A (zh) * 2010-12-09 2012-10-03 江南大学 一种以离子液体作为添加剂的反向微乳毛细管电动色谱分析化妆品中的糖皮质激素的方法
US9549891B2 (en) 2012-03-19 2017-01-24 The Procter & Gamble Company Superabsorbent polymers and sunscreen actives for use in skin care compositions
WO2014046983A1 (en) 2012-09-21 2014-03-27 Intensity Therapeutic Method of treating cancer
US10105467B2 (en) * 2013-01-22 2018-10-23 Rutgers, The State University Of New Jersey Biocompatible polymer compositions for tissue void filling
EP3281626B1 (en) 2015-04-06 2023-08-23 LG Household & Health Care Ltd. Soluble microneedle for delivering poorly-soluble drug
JP6604637B2 (ja) 2015-06-29 2019-11-13 ザ プロクター アンド ギャンブル カンパニー スキンケア組成物において使用するための超吸収性ポリマー及びデンプン粉末
WO2017155267A1 (ko) * 2016-03-07 2017-09-14 성균관대학교산학협력단 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법
KR101956444B1 (ko) * 2016-03-07 2019-03-08 성균관대학교산학협력단 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법
CA3029012C (en) 2016-06-28 2024-10-01 Institut National De La Sante Et De La Rech Medicale Inserm Hycanthone derivatives and primaquine derivatives intended for use in preventing and/or treating conditions associated with Gammaherpesvirinae
CN110381921A (zh) 2016-11-15 2019-10-25 卡里亚制药控股有限公司 药物制剂
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
CN112105908A (zh) * 2018-05-17 2020-12-18 株式会社资生堂 角质层采集用粘合组合物、角质层采集工具、生物物质提取试剂盒和生物物质采集方法
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
JP2022553184A (ja) * 2019-10-18 2022-12-22 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ すすぎ特性を確認する方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980449A (en) 1988-07-14 1990-12-25 Rutgers, The State University Polyiminocarbonate synthesis
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5099060A (en) 1990-06-12 1992-03-24 Rutgers, The State University Of New Jersey Synthesis of amino acid-derived bioerodible polymers
US5216115A (en) 1990-06-12 1993-06-01 Rutgers, The State University Of New Jersey Polyarylate containing derivatives of the natural amino acid L-tyrosine
US5658995A (en) * 1995-11-27 1997-08-19 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
US6120491A (en) 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
JP4465105B2 (ja) * 1997-11-07 2010-05-19 ルトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー 放射線不透過性ポリマー生体適合材料
US6468980B1 (en) * 2000-09-01 2002-10-22 Oxycal Laboratories, Inc. Methods and compositions for potentiating cancer chemotherapeutic agents
FR2830773B1 (fr) * 2001-10-11 2004-07-23 Oreal Utilisation de copolymeres amphiphiles pour stabiliser des dispersions de composes organiques insolubles filtrant le rayonnement uv, dispersions stabilisees par ces copolymeres et compositions cosmetiques les contenant
US8591951B2 (en) 2002-05-15 2013-11-26 Joachim B. Kohn Tri-block copolymers for nanosphere-based drug delivery
CN100503673C (zh) * 2005-07-07 2009-06-24 复旦大学 具有疏水核心、亲水表面的纳米粒及其制备方法和应用

Also Published As

Publication number Publication date
WO2008095144A3 (en) 2008-11-27
WO2008095144A2 (en) 2008-08-07
EP3542785A1 (en) 2019-09-25
AU2008210329A1 (en) 2008-08-07
AU2008210329B2 (en) 2013-11-28
US20090317472A1 (en) 2009-12-24
EP2114377A4 (en) 2012-08-01
CA2676841A1 (en) 2008-08-07
EP2114377B1 (en) 2018-10-17
US8414871B2 (en) 2013-04-09
EP2114377A2 (en) 2009-11-11
CA2676841C (en) 2017-09-26
CN101668512A (zh) 2010-03-10
NZ578693A (en) 2011-08-26

Similar Documents

Publication Publication Date Title
MX2009008030A (es) Liberacion controlada de activos en la piel.
BR0315304A (pt) Formulações com depósito para liberação controlada
SG151271A1 (en) Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
DE60118776D1 (de) Polymerisierbare, flüssigkristalline dioxetane, deren herstellung und verwendung
ATE315407T1 (de) Verbindungen mit einer sulfonamidgruppe und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE60224296D1 (de) Haarpflegezusammensetzungen
WO2013006743A3 (en) Personal care compositions with improved solubility of a solid cosmetic active substance
WO2008151460A3 (en) Cooling compounds
MX2010009395A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos.
SE0201659D0 (sv) Modified release pharmaceutical formulation
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL212596A0 (en) Octenidine composition
MX2009010559A (es) Derivados de heteroarilo.
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1238654A3 (en) Composition for external application containing a diamide derivative
ATE422163T1 (de) Absorbierbare alpha-cyanacrylat-zusammensetzungen
ATE528009T1 (de) Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
ATE548019T1 (de) Hautaufhellende mittel, zusammensetzungen und verfahren
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0203070D0 (en) Novel compounds
AR059113A1 (es) Composicion para administracion topica
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BRPI0711425A8 (pt) composições compreendendo tensoativos polimerizados de baixo dp e métodos de uso destas
TW200637599A (en) Cosmetic
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration